01090nas a2200157   4500000000100000008004100001260003800042100001400080700001400094700001400108245011600122856009200238300001000330520057400340020001800914       2023                            d  bSpringer International Publishing1 aVermaak S1 aSampson S1 aMcShane H00aThe VALIDATE Network: Accelerating Vaccine Development for Tuberculosis, Leishmaniasis, Melioidosis and Leprosy  uhttps://link.springer.com/content/pdf/10.1007/978-3-031-24355-4_2.pdf?pdf=inline%20link  a11-253 a<p>Established in June 2017, VALIDATE is an international network of researchers working to accelerate vaccine development for four neglected intracellular pathogens that cause significant mortality and morbidity globally: Mycobacterium tuberculosis, Leishmania spp., Burkholderia pseudomallei and Mycobacterium leprae. In 5&nbsp;years, VALIDATE has grown to have more than 550 members from over 250 institutes across 72 countries and has had several successes and important outputs. This chapter discusses VALIDATE’s origins, achievements and future direction.</p>
  a9783031243547